PKO Investment Management Joint-Stock’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $782K | Sell |
10,000
-7,000
| -41% | -$547K | 0.08% | 141 |
|
|
2025
Q1 | $1.23M | Buy |
17,000
+9,000
| +113% | +$652K | 0.14% | 109 |
|
|
2024
Q4 | $592K | Sell |
8,000
-6,000
| -43% | -$444K | 0.07% | 133 |
|
|
2024
Q3 | $924K | Buy |
14,000
+8,000
| +133% | +$528K | 0.11% | 115 |
|
|
2024
Q2 | $554K | Buy |
6,000
+3,500
| +140% | +$323K | 0.07% | 142 |
|
|
2024
Q1 | $240K | Sell |
2,500
-12,500
| -83% | -$1.2M | 0.03% | 156 |
|
|
2023
Q4 | $1.14M | Sell |
15,000
-5,000
| -25% | -$381K | 0.14% | 97 |
|
|
2023
Q3 | $1.39M | Buy |
20,000
+12,800
| +178% | +$887K | 0.19% | 77 |
|
|
2023
Q2 | $679K | Hold |
7,200
| – | – | 0.08% | 126 |
|
|
2023
Q1 | $596K | Hold |
7,200
| – | – | 0.08% | 124 |
|
|
2022
Q4 | $537K | Hold |
7,200
| – | – | 0.08% | 115 |
|
|
2022
Q3 | $595K | Hold |
7,200
| – | – | 0.1% | 108 |
|
|
2022
Q2 | $685K | Sell |
7,200
-3,278
| -31% | -$312K | 0.1% | 104 |
|
|
2022
Q1 | $1.23M | Hold |
10,478
| – | – | 0.15% | 94 |
|
|
2021
Q4 | $1.36M | Buy |
+10,478
| New | +$1.36M | 0.15% | 90 |
|